Literature DB >> 16807764

Non-lethal fetal toxicity of the angiotensin receptor blocker candesartan.

Giacomo D Simonetti, Thomas Baumann, Jana M Pachlopnik, Rodo O von Vigier, Mario G Bianchetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16807764     DOI： 10.1007/s00467-006-0162-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  6 in total

Review 1.  Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?

Authors:  M Volpe; L M Ruilope; G T McInnes; B Waeber; M A Weber
Journal:  J Hum Hypertens       Date:  2005-05       Impact factor: 3.012

Review 2.  Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.

Authors:  Albert Quan
Journal:  Early Hum Dev       Date:  2006-01-19       Impact factor: 2.079

Review 3.  Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.

Authors:  Gerd Bönner; Winfried Fuchs
Journal:  Curr Med Res Opin       Date:  2005-06       Impact factor: 2.580

Review 4.  Angiotensin II receptor antagonist treatment during pregnancy.

Authors:  S Alwan; J E Polifka; J M Friedman
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2005-02

Review 5.  Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?

Authors:  Karl F Hilgers; Jörg Dötsch; Wolfgang Rascher; Johannes F E Mann
Journal:  Pediatr Nephrol       Date:  2004-07-22       Impact factor: 3.714

Review 6.  Recognition and management of angiotensin converting enzyme inhibitor fetopathy.

Authors:  A B Sedman; D B Kershaw; T E Bunchman
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714
  6 in total
  4 in total

1.  Postnatal acute renal failure after fetal exposure to angiotensin receptor blockers.

Authors:  Luca Marchetto; Desiree Sordino; Giuseppe De Bernardo; Daniele Trevisanuto
Journal:  BMJ Case Rep       Date:  2015-07-02

Review 2.  Outcomes of 83 fetuses exposed to angiotensin receptor blockers during the second or third trimesters: a literature review.

Authors:  Chisa Shimada; Rina Akaishi; Kazutoshi Cho; Mamoru Morikawa; Yosuke Kaneshi; Takahiro Yamda; Hisanori Minakami
Journal:  Hypertens Res       Date:  2015-02-19       Impact factor: 3.872

Review 3.  Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents.

Authors:  Siegtraut Dorothea Herder; Ernst Weber; Almuth Winkemann; Christoph Herder; Hartmut Morck
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

4.  The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.

Authors:  Myla E Moretti; Daniela Caprara; Irina Drehuta; Emily Yeung; Stefanie Cheung; Lisa Federico; Gideon Koren
Journal:  Obstet Gynecol Int       Date:  2011-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.